Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish

Neuro-Oncology

Volumn 15, Issue 3, 2013, Pages 290-304

  Jung, In Hye ^a   Leem, Ga Lam ^b   Jung, Dawoon E ^c   Kim, Min Hee ^c   Kim, Eun Young ^c   Kim, Se Hoon ^c   Park, Hae Chul ^d   Park, Seung Woo ^c  

^a Postgraduate School of National Core Research Center for Nanomedical Technology   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Akt1; epithelial mesenchymal transition; glioma; Rac1; transgenic zebrafish

Indexed keywords

AKT 1 PROTEIN; BETA CATENIN; CYCLIN D1; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RAC1 PROTEIN; SNAIL 1A PROTEIN; SURVIVIN; SURVIVIN 2; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FOURTH VENTRICLE; CANCER GRADING; CANCER INCIDENCE; CANCER INHIBITION; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CEREBELLUM; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE EXPRESSION; GLIOMA; HISTOPATHOLOGY; HUMAN; MEDULLA OBLONGATA; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC ANIMAL; UPREGULATION; ZEBRA FISH;

EID: 84874519918     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos387     Document Type: Article

References (57)

1. Louis DN. Molecular pathology of malignant gliomas. Ann Rev Pathol. 2006;1:97-117.
2. Rousseau A, Mokhtari K, Duyckaerts C. The 2007 WHO classification of tumors of the central nervous system-what has changed? Curr Opin Neurol. 2008;21:720-727.
3. Gladson CL, Prayson RA, Liu WM. The pathobiology of glioma tumors. Ann Rev Pathol. 2010;5:33-50.
4. Rossig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol. 2001;21:5644-5657. (Pubitemid 32702467)
5. Mayo LD, Donner DB. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA. 2001;98:11598-11603. (Pubitemid 32928774)
6. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-1068.
7. Dahia PL, Aguiar RC, Alberta J, et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum Mol Genet. 1999;8:185-193. (Pubitemid 29054260)
8. Bos JL. A target for phosphoinositide 3-kinase: Akt/PKB. Trends Biochem Sci. 1995;20:441-442.
9. Daly C, Wong V, Burova E, et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 2004;18:1060-1071. (Pubitemid 38620245)
10. Dan HC, Jiang K, Coppola D, et al. Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis. Oncogene. 2004;23:706-715. (Pubitemid 38241271)
11. Hideshima T, Catley L, Raje N, et al. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells. Br J Haematol. 2007;138:783-791. (Pubitemid 47313207)
12. Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem. 2000;275:9102-9105. (Pubitemid 30185122)
13. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse differentiation. Am J Pathol. 1998;152:43-49. (Pubitemid 28028045)
14. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917-921. (Pubitemid 27353455)
15. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580-584. (Pubitemid 28563719)
16. Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998;58:5315-5320. (Pubitemid 28551107)
17. Karra L, Shushan A, Ben-Meir A, et al. Changes related to phosphatidylinositol 3-kinase/Akt signaling in leiomyomas: possible involvement of glycogen synthase kinase 3a and cyclin D2 in the pathophysiology. Fertil Steril. 2010;93:2646-2651.
18. Gotoh J, Obata M, Yoshie M, Kasai S, Ogawa K. Cyclin D1 overexpression correlates with b-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3b and ERK1/2 in mouse hepatic carcinogenesis. Carcinogenesis. 2003;24:435-442. (Pubitemid 36432638)
19. Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279: 509-514. (Pubitemid 28067271)
20. Braga VM, Machesky LM, Hall A, Hotchin NA. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cellcell contacts. J Cell Biol. 1997;137:1421-1431. (Pubitemid 27265952)
21. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol. 1999;147:1009-1022.
22. Yamazaki D, Kurisu S, Takenawa T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene. 2009;28:1570-1583.
23. Symons M, Segall JE. Rac and Rho driving tumor invasion: who's at the wheel? Genome Biol. 2009;10:213.
24. Goldberg L, Kloog Y. A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration. Cancer Res. 2006;66:11709-11717. (Pubitemid 46094183)
25. Senger DL, Tudan C, Guiot MC, et al. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes. Cancer Res. 2002;62:2131-2140. (Pubitemid 34408462)
26. Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, Long F. Rac1 activation controls nuclear localization of b-catenin during canonical Wnt signaling. Cell. 2008;133:340-353. (Pubitemid 351508298)
27. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 2000;25:55-57. (Pubitemid 30257036)
28. Pisharath H, Parsons MJ. Nitroreductase-mediated cell ablation in transgenic zebrafish embryos. Methods Mol Biol. 2009;546:133-143.
29. Jung IH, Jung DE, Park YN, Song SY, Park SW. Aberrant hedgehog ligands induce progressive pancreatic fibrosis by paracrine activation of myofibroblasts and ductular cells in transgenic zebrafish. PloS One. 2011;6:1-15.
30. Bernardos RL, Raymond PA. GFAP transgenic zebrafish. Gene Expr Patterns. 2006;6:1007-1013. (Pubitemid 44334732)
31. Yeo SY, Kim M, Kim HS, Huh TL, Chitnis AB. Fluorescent protein expression driven by her4 regulatory elements reveals the spatiotemporal pattern of Notch signaling in the nervous system of zebrafish embryos. Dev Biol. 2007;301:555-567. (Pubitemid 46073984)
32. Kim H, Shin J, Kim S, Poling J, Park HC, Appel B. Notch-regulated oligodendrocyte specification from radial glia in the spinal cord of zebrafish embryos. Dev Dyn. 2008;237:2081-2089.
33. Workman P, Aboagye EO, Balkwill F, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102: 1555-1577.
34. Park SW, Davison JM, Rhee J, Hruban RH, Maitra A, Leach SD. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology. 2008;134:2080-2090. (Pubitemid 351783259)
35. Janezic G, Widni EE, Haxhija EQ, Stradner M, Frohlich E, Weinberg AM. Proliferation analysis of the growth plate after diaphyseal midshaft fracture by 5′-bromo-2′-deoxy-uridine. Virchows Arch. 2010;457:77-85.
36. Davison JM, Woo Park S, Rhee JM, Leach SD. Characterization of Kras-mediated pancreatic tumorigenesis in zebrafish. Methods Enzymol. 2008;438:391-417.
37. Beckers T, Voegeli R, Hilgard P. Molecular and cellular effects of hexadecylphosphocholine (Miltefosine) in human myeloid leukaemic cell lines. Eur J Cancer. 1994;30A:2143-2150.
38. Larson B, Banks P, Zegzouti H, Goueli SA. A simple and robust automated kinase profiling platform using luminescent ADP accumulation technology. Assay Drug Dev Techn. 2009;7:573-584.
39. Lin JW, Biankin AV, Horb ME, et al. Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. Dev Biol. 2004;270:474-486. (Pubitemid 38748566)
40. Kroehne V, Freudenreich D, Hans S, Kaslin J, Brand M. Regeneration of the adult zebrafish brain from neurogenic radial glia-type progenitors. Development. 2011;138:4831-4841.
41. Jung SH, Kim HS, Ryu JH, et al. Her4-positive population in the tectum opticum is proliferating neural precursors in the adult zebrafish brain. Mol Cells. 2012;33:627-632.
42. Kaslin J, Ganz J, Geffarth M, Grandel H, Hans S, Brand M. Stem cells in the adult zebrafish cerebellum: initiation and maintenance of a novel stem cell niche. J Neurosci. 2009;29:6142-6153.
43. Meadows KN, Iyer S, Stevens MV, et al. Akt promotes endocardialmesenchyme transition. J Angiogenes Res. 2009;1:2.
44. Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2008;8:61-70.
45. Ramnanan CJ, Groom AG, Storey KB. Akt and its downstream targets play key roles in mediating dormancy in land snails. Comp Biochem Physiol B Biochem Mol Biol. 2007;148:245-255. (Pubitemid 47628907)
46. Dutcher JP. Mammalian target of rapamycin (mTOR) inhibitors. Curr Oncol Rep. 2004;6:111-115. (Pubitemid 38898838)
47. Hoshino M, Nakamura S, Mori K, et al. Ptf1a, a bHLH transcriptional gene defines GABAergic neuronal fates in cerebellum. Neuron. 2005;47:201-213. (Pubitemid 41019252)
48. Onvani S, Etame AB, Smith CA, Rutka JT. Genetics of medulloblastoma; clues for novel therapies. Expert Rev Neurother. 2010;10:811-823.
49. Liu T, Biddle D, Hanks AN, et al. Activation of dual apoptotic pathways in human melanocytes and protection by survivin. J Invest Dermatol. 2006;126:2247-2256. (Pubitemid 44413172)
50. Wagenknecht B, Glaser T, Naumann U, et al. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Diff. 1999;6:370-376. (Pubitemid 29186881)
51. Zhao P, Meng Q, Liu LZ, You YP, Liu N, Jiang BH. Regulation of survivin by PI3K/Akt/p70S6K1 pathway. Biochem Biophy Res Comm. 2010;395:219-224.
52. Zondag GC, Evers EE, ten Klooster JP, Janssen L, van der Kammen RA, Collard JG. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J Cell Biol. 2000;149:775-782.
53. Phelps RA, Chidester S, Dehghanizadeh S, et al. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell. 2009;137:623-634.
54. Julien S, Puig I, Caretti E, et al. Activation of NF-kB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene. 2007;26:7445-7456. (Pubitemid 350158710)
55. Gos M, Miloszewska J, Przybyszewska M. Epithelial-mesenchymal transition in cancer progression. Postepy Biochem. 2009;55: 121-128.
56. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 2010;15:117-134.
57. Ansieau S, Caron de Fromentel C, Bastid J, Morel AP, Puisieux A. Role of the epithelial-mesenchymal transition during tumor progression. Bull Cancer. 2010;97:7-15.